India
Good News with Big Boost! India’s first intranasal COVID-19 vaccine by Bharat Biotech gets DCGI approval
Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a ‘Big boost’ to India’s fight against Covid-19.
New Delhi: The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India (DCGI) for the Intranasal Covid-19 vaccine.
This will be India’s first nasal vaccine for COVID-19.
Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a ‘Big boost’ to India’s fight against Covid-19.
He took to Twitter and said, “Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation.”
“This step will further strengthen our collective fight against the pandemic. India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership,” he added.
He also said that we will defeat Covid-19 with a science-driven approach.
“With the science-driven approach and Sabka Prayas, we will defeat COVID-19,” he said.
Gujarat polls: Voting in first phase on Thursday; key seats and players to watch out for
Words Kharge used for PM isn’t only his mentality but result of entire Congress mentality: Rajnath
Ravish Kumar resigns from NDTV after Adani’s takeover; Twitter flooded with funny memes
Top 10 OTT movies of 2022, that didn’t create buzz but are a MUST WATCH
Tendulkar to Kohli: Meet India’s Top 10 richest cricketers who have built ’empire’ worth crores
Crypto currency news: Know about Hyperverse Crypto; is it scam?
Aftab Poonawala Kills Shraddha Walkar: Man kills live-in partner, chops of body in 35 pieces, held in Delhi
FIFA WORLD CUP 2022: How many countries participating in tournament?
